Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin's lymphoma.

Hopfinger, G

Ifosfamide, mitoxantrone and etoposide (VIM) as salvage therapy of low toxicity in non-Hodgkin's lymphoma. [electronic resource] - European journal of haematology Oct 1995 - 223-7 p. digital

Publication Type: Comparative Study; Journal Article

0902-4441

10.1111/j.1600-0609.1995.tb00261.x doi


Adolescent
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Bone Marrow Transplantation
Etoposide--administration & dosage
Female
Humans
Ifosfamide--administration & dosage
Lymphoma, Non-Hodgkin--drug therapy
Male
Methotrexate--administration & dosage
Middle Aged
Neoplasm Staging
Prognosis
Recurrence
Retrospective Studies
Salvage Therapy
Survival Rate
Time Factors
Transplantation, Autologous